Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
- Published Date: 2020-10-13
- Report ID: 1810
- Pages: 190
-
Format:
REPORT HIGHLIGHT
Infectious Diseases In Vitro Diagnostics market was valued at USD 16.1 billion by 2019, growing with 7.3% CAGR during the forecast period, 2020-2026
Market Dynamics
The favorable government initiatives and the rise in external funds for R&D purposes are some of the major factors driving the growth of global infectious diseases in vitro diagnostics market. In addition, the increasing geriatric population all across the globe are other key factors boosting the market growth. According to the World Population Aging Report by United Nations (UN), in 2019, the number of elderly people aged 80 years and older were estimated for 143 million and this number is projected to reach 426 million by the end of 2050. Moreover, the shift towards self-care clinical devices, growing health awareness, and the rising burden of target diseases are some of the contributors to the growth of the global market for infectious diseases IVD market. Conversely, a dearth of stringent regulatory framework and expenses associated with in-vitro diagnostic tests are predicted to hinder the market growth during the forecast period. Furthermore, the advancements in IVD kits such as improved patient compliance, sensitivity, and speed is likely to create lucrative opportunities in the global market in the coming future.
Presently, the North America region is playing a leading role in the global infectious diseases IVD market and is estimated to dominate the industry throughout the forecast. This dominance is attributed to the presence of well-established healthcare infrastructure, proactive government initiatives, and growing awareness levels of patients and practitioners in this region.
Further key findings of the report suggest:
The reagents product segment held the largest market share in the overall market in 2019 and is expected to grow at a healthy rate during the forecast period. This is mainly due to increasing demand for point-of-care & self-test products and the growth in the number of R&D initiatives related to molecular diagnostic tools.
The HIV tests segment valued for the majority of share in the infectious diseases IVD market in 2019 owing to the rapidly rising disease burden and highly unmet medical needs in the developing countries.
The immunochemistry technology segment accounted for the highest revenue share in the worldwide industry in 2019, followed thoroughly by molecular diagnostics. Nevertheless, molecular diagnostics technology is projected to be the largest segment by the end of 2030. This is mainly due to the increasing demand for rapid new-age, accurate, and sensitive devices and rising penetration for diagnosing infectious diseases.
The central laboratories end use segment emerged as the largest in 2019, which is primarily driven by the large volume of tests carried out these laboratories. On the other hand, the point-of-care (PoC) end use segment is projected to witness the highest growth rate during the period of forecast. This is majorly owing to the rising need for rapid diagnosing and the increase in initiatives intended to lessen hospital stays to bound healthcare expenditure.
The Asia Pacific market for infectious diseases IVD is projected to record the highest growth rate in the estimated period owing to the high unmet medical needs, presence of favorable government initiatives for testing infectious disease, the rise in healthcare spending in countries such as India, China, South Korea, and an increase in disposable income in this region.
Key participants of the overall infectious diseases IVD market include bioMrieux SA, Alere Inc., Abbott, Quidel Corporation, Orasure Technologies, Inc., F. Hoffmann-La Roche Ltd., Cepheid, Qiagen N.V., Hologic Inc., and Siemens Healthcare GmbH.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year 2015 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
Molecular Diagnostics
Immunochemistry
Microbiology
Others
GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY PRODUCT
Reagents
Instruments
Software
Others
GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
Gonorrhoea
HPV
HIV
MRSA
Streptococcus
Clostridium Difficile
VRE
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Hepatitis B
Hepatitis C
CRE
Respiratory Virus
Candida
Chlamydia
Others
GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY END USE
Central Laboratories
Point of Care
Others
GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY REGION
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA
TABLE OF CONTENT
1. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product
2.1.2. Market Snippet by Technology
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by End Use
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS INDUSTRY STUDY
4.1. Porters Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET BY PRODUCT
6.1. Overview
6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
6.2. Reagents
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3. Instruments
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.4. Software
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5. Others
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET BY TECHNOLOGY
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
7.2. Molecular Diagnostics
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.3. Immunochemistry
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.4. Microbiology
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.5. Others
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET BY APPLICATION
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
8.2. Gonorrhoea
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3. HPV
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4. HIV
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5. MRSA
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.6. Streptococcus
8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.7. Clostridium Difficile
8.7.1. Overview
8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.8. VRE
8.8.1. Overview
8.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.9. TB and Drug-resistant TB
8.9.1. Overview
8.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.10. Gastro-intestinal Panel Testing
8.10.1. Overview
8.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.11. Hepatitis B
8.11.1. Overview
8.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.12. Hepatitis C
8.12.1. Overview
8.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.13. CRE
8.13.1. Overview
8.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.14. Respiratory Virus
8.14.1. Overview
8.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.15. Candida
8.15.1. Overview
8.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.16. Chlamydia
8.16.1. Overview
8.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.17. Others
8.17.1. Overview
8.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET BY END USE
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
9.2. Central Laboratories
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3. Point of Care
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4. Others
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
10.2.7. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
10.2.8. U.S.
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.2.9. Canada
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
10.3.7. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
10.3.8. Germany
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.3.10. United Kingdom
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.3.11. France
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.3.12. Rest of Europe
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
10.4.7. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.4.9. China
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.4.11. South Korea
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.4.12. Rest of APAC
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
10.5.7. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
10.5.8. Brazil
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.5.9. Mexico
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.5.10. Argentina
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
10.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
10.6.8. Saudi Arabia
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10.6.9. United Arab Emirates
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Abbott
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiatives
11.2. bioMrieux SA
11.3. Cepheid
11.4. Qiagen N.V.
11.5. Hologic Inc.
11.6. Siemens Healthcare GmbH
11.7. Alere Inc.
11.8. Quidel Corporation
11.9. Orasure Technologies
11.10. F. Hoffmann-La Roche Ltd.
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
